NanoString Technologies Inc (NSTGQ)
0.205
+0.03
(+15.75%)
USD |
OTCM |
May 03, 16:00
NanoString Technologies Cash from Operations (TTM): -114.98M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -114.98M |
June 30, 2023 | -133.08M |
March 31, 2023 | -134.10M |
December 31, 2022 | -128.61M |
September 30, 2022 | -118.04M |
June 30, 2022 | -109.10M |
March 31, 2022 | -91.95M |
December 31, 2021 | -90.55M |
September 30, 2021 | -83.91M |
June 30, 2021 | -75.69M |
March 31, 2021 | -82.74M |
December 31, 2020 | -81.66M |
September 30, 2020 | -90.32M |
June 30, 2020 | -90.40M |
March 31, 2020 | -89.03M |
December 31, 2019 | -89.42M |
September 30, 2019 | -84.30M |
June 30, 2019 | -74.90M |
March 31, 2019 | -64.39M |
December 31, 2018 | -54.06M |
September 30, 2018 | -52.00M |
June 30, 2018 | -51.01M |
Date | Value |
---|---|
March 31, 2018 | -54.24M |
December 31, 2017 | -51.66M |
September 30, 2017 | -45.73M |
June 30, 2017 | -39.36M |
March 31, 2017 | -28.93M |
December 31, 2016 | -6.079M |
September 30, 2016 | -4.249M |
June 30, 2016 | -7.777M |
March 31, 2016 | -19.06M |
December 31, 2015 | -43.36M |
September 30, 2015 | -43.64M |
June 30, 2015 | -48.65M |
March 31, 2015 | -41.72M |
December 31, 2014 | -38.06M |
September 30, 2014 | -43.04M |
June 30, 2014 | -37.78M |
March 31, 2014 | -35.39M |
December 31, 2013 | -31.35M |
September 30, 2013 | -25.15M |
June 30, 2013 | -21.89M |
March 31, 2013 | -20.90M |
December 31, 2012 | -14.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-134.10M
Minimum
Mar 2023
-74.90M
Maximum
Jun 2019
-97.93M
Average
-90.36M
Median
Cash from Operations (TTM) Benchmarks
Bruker Corp | 284.40M |
Azenta Inc | 70.94M |
Harvard Bioscience Inc | 14.03M |
Bionano Genomics Inc | -125.18M |
Akoya Biosciences Inc | -50.90M |